CMMB- Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. (CMMB) has 1 insider with recent SEC Form 4 filings, including 12 buys and 7 sells. CMMB is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 134.2K | $241.6K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | Mor George Adi | Chief Executive Officer | Buy | 9,804 | $2.07 | $20,245.98 | +3.7% | - | - | |
| Jan 3, 2023 | Mor George Adi | Chief Scientific Officer | Sell | 13,800 | $5.03 | $69,369.84 | -2.4% | -49.0% | -81.8% | |
| Jan 3, 2023 | Orbimed Israel GP Ltd. | 10% Owner | Sell | 336,900 | $3.58 | $1,207,759.08 | -6.9% | -49.0% | -81.8% | |
| Nov 16, 2022 | Cohen Neil Harris | Director | Sell | 2,409 | $2.00 | $4,818.00 | -19.4% | -9.2% | -71.1% | |
| Nov 16, 2022 | Mor George Adi | Chief Scientific Officer | Sell | 582,023 | $2.08 | $1,213,401.55 | -50.0% | -9.2% | -71.1% | |
| May 24, 2022 | Maryles Joel Michael | Director | Buy | 433 | $2.88 | $1,247.08 | +18.0% | +15.7% | -39.6% | |
| May 18, 2022 | Cohen Neil Harris | Director | Buy | 2,000 | $3.19 | $6,380.00 | +19.2% | +21.9% | -39.9% | |
| Mar 18, 2022 | Maryles Joel Michael | Director | Buy | 1,000 | $4.34 | $4,340.00 | +200.0% | -27.5% | -67.2% | |
| Mar 16, 2022 | Marvin Donald | Executive VP, CFO &COO | Buy | 500 | $3.28 | $1,637.50 | +15.4% | -21.0% | -63.7% | |
| Mar 14, 2022 | Cohen Neil Harris | Director | Buy | 6,000 | $4.35 | $26,120.00 | +31.2% | -15.4% | -62.5% |
Page 1Next →